Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

AXYX

Axonyx (AXYX)

Axonyx
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AXYX
DateTimeSourceHeadlineSymbolCompany
29/09/200606:15Business WireAxonyx Stockholders Approve Merger with TorreyPines Therapeutics Inc.NASDAQ:AXYXAxonyx
22/09/200601:00PR Newswire (US)TorreyPines Therapeutics to Present at the UBS Global Life Sciences ConferenceNASDAQ:AXYXAxonyx
31/08/200601:00PR Newswire (US)TorreyPines Therapeutics to Present at the Thomas Weisel Partners 2006 Healthcare ConferenceNASDAQ:AXYXAxonyx
08/08/200622:30Business WireAXONYX Inc. Announces Second Quarter 2006 Financial ResultsNASDAQ:AXYXAxonyx
07/08/200623:30PR Newswire (US)TorreyPines Therapeutics Initiates Phase I Clinical Trial of NGX426, a Novel Oral Therapy for Migraine and Neuropathic PainNASDAQ:AXYXAxonyx
05/08/200606:30Business WireAxonyx Receives Notice Related to Nasdaq Minimum Bid Price RuleNASDAQ:AXYXAxonyx
24/07/200623:30PR Newswire (US)TorreyPines Therapeutics Completes Second Phase I Study for NGX267, a Selective M1 Agonist for the Treatment of Alzheimer's DisNASDAQ:AXYXAxonyx
21/06/200601:00PR Newswire (US)TorreyPines Therapeutics to Present at the Jefferies & Company Life Sciences ConferenceNASDAQ:AXYXAxonyx
10/06/200601:34PR Newswire (US)TorreyPines Therapeutics to Present at the 2006 Pacific Growth Equities Life Sciences Growth ConferenceNASDAQ:AXYXAxonyx
08/06/200622:00Business WireAxonyx and TorreyPines to Host Webcast and Conference Call on Announced MergerNASDAQ:AXYXAxonyx
08/06/200620:30Business WireAxonyx and TorreyPines Therapeutics Announce Merger Agreement; Transaction Creates Robust Portfolio in the CNS Disease AreaNASDAQ:AXYXAxonyx
16/05/200606:15Business WireAxonyx Announces Completion of the Multiple-Dose Phase I Study of Posiphen(TM)NASDAQ:AXYXAxonyx
11/05/200607:30Business WireAxonyx Inc. Reports First Quarter 2006 Financial ResultsNASDAQ:AXYXAxonyx
09/05/200623:28Business WireAxonyx to Present at the Rodman & Renshaw 3rd Annual Global Healthcare Conference; Presentation to be Web Cast Live on CorporatNASDAQ:AXYXAxonyx
24/04/200622:30Business WireResearcher Reports Data on Effects of Posiphen(TM) on Human Neuronal Stem Cells; Posiphen May Support Stem Cell TransplantationNASDAQ:AXYXAxonyx
21/04/200606:30Business WireAxonyx Reports Data on Effects of Phenserine on the Brains of Alzheimer's Disease Patients; PET Scans Show Increased Brain NeurNASDAQ:AXYXAxonyx
20/04/200606:30Business WireAxonyx Reports Data on Stabilized Brain Volumes in Alzheimer's Disease Patients Treated with Phenserine; Analysis of Brain ScanNASDAQ:AXYXAxonyx
17/03/200608:15Business WireAxonyx Reports Fourth Quarter and Full Year 2005 Financial ResultsNASDAQ:AXYXAxonyx
09/03/200608:24Business WireAxonyx Regains Compliance with Nasdaq Minimum Bid Price RuleNASDAQ:AXYXAxonyx
24/02/200600:33Business WireAxonyx to Present at the Wall Street Analyst Forum; Presentation to be Web Cast Live on Corporate Web SiteNASDAQ:AXYXAxonyx
15/02/200600:33Business WireAxonyx Reports Phenserine Associated with Significant Amyloid Reduction in Phase I Trial; Results Support Dual Mechanisms of ActNASDAQ:AXYXAxonyx
08/02/200601:00Business WireAxonyx to Present at BIO CEO & Investor Conference 2006; Presentation to be Web Cast Live on Corporate Web SiteNASDAQ:AXYXAxonyx
01/02/200600:30Business WireAxonyx Announces Acceptance of Four Abstracts Highlighting Phenserine and Posiphen by the 9th International Geneva/Springfield SNASDAQ:AXYXAxonyx
25/01/200600:30Business WireAxonyx Completes First Phase I Trial with Posiphen for Alzheimer's Disease ProgressionNASDAQ:AXYXAxonyx
05/01/200600:30Business WireAxonyx Announces License of Phenserine to Daewoong Pharmaceutical Company for South KoreaNASDAQ:AXYXAxonyx
10/11/200500:30Business WireAxonyx Inc. Announces Third Quarter Financial ResultsNASDAQ:AXYXAxonyx
08/11/200508:47Business WireAxonyx Provides Update on Clinical Development Program and Strategic InitiativesNASDAQ:AXYXAxonyx
26/10/200522:00Business WireAxonyx to Present at Rodman & Renshaw Techvest 7th Annual Healthcare Conference; Presentation to Be Web Cast Live on Corporate WNASDAQ:AXYXAxonyx
20/09/200523:00Business WireAxonyx Announces Results of Curtailed Phase III Clinical Trials for Phenserine in Alzheimer's DiseaseNASDAQ:AXYXAxonyx
15/09/200522:30Business WireAxonyx to Present at the UBS 2005 Global Life Sciences Conference; Presentation to be Web Cast Live on Corporate Web SiteNASDAQ:AXYXAxonyx
 Showing the most relevant articles for your search:NASDAQ:AXYX